Table 2.

Relative survival (%) at 1, 3 and 5 years in patients diagnosed with hepatocellular carcinoma in Scotland during 1985–2008 (n = 2802)

	1-year survival, % (95% CI)		3-year survival, % (95% CI)		5-year survival, % (95% CI)
Women
1985–1989	10.7	(5.6–17.7)	2.4	(0.6–6.9)	0.5	(0.0–3.7)
1990–1994	14.6	(8.6–22.0)	5.4	(2.1–11.0)	5.4	(2.1–11.0)
1995–1999	16.3	(10.8–22.8)	9.7	(5.5–15.4)	7.1	(3.6–12.2)
2000–2004	28.2	(21.3–35.5)	11.6	(7.0–17.5)	8.7	(4.7–14.2)
2005–2007	32.1	(24.1–40.4)	12.6	(7.2–19.6)	10.6	(5.2–18.1)
Men
1985–1989	5.2	(3.1–8.0)	0.7	(0.2–2.2)	0.4	(0.2–2.2)
1990–1994	9.2	(6.5–12.6)	3.2	(1.6–5.7)	2.2	(0.9–4.5)
1995–1999	18.4	(14.9–22.3)	7.9	(5.5–10.8)	5.5	(3.5–8.3)
2000–2004	26.7	(22.9–30.7)	11.0	(8.3–14.1)	8.7	(6.2–11.6)
2005–2007	26.8	(22.8–30.8)	11.8	(8.9–15.2)	4.4	(1.5–9.9)

95% CI, 95% confidence interval.